David C. Swinney

Molecular Biology · 2011

A researcher in the Science corpus: 1 paper; trusts 4 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom David C. Swinney trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. D. Newman
  2. B. Munos
  3. Joseph Schlessinger
  4. G. Cragg
  5. John P. Overington
  6. Yves Pommier
  7. P. Conn

Who trusts David C. Swinney overall

  1. Leonard Katz
  2. D. Huh
  3. Juan C. Caicedo

Papers from David C. Swinney's perspective

Ordered by how strongly the researchers David C. Swinney trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug (Nature reviews. Drug discovery)
  2. Drugs, their targets and the nature and number of drug targets (Nature reviews. Drug discovery)
  3. How many drug targets are there?
  4. Cell signaling by receptor tyrosine kinases.
  5. The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP (Proceedings of the National Academy of Sciences of the United States of America)
  6. Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders (Nature reviews. Drug discovery)
  7. Protein therapeutics: a summary and pharmacological classification (Nature reviews. Drug discovery)
  8. Natural products as sources of new drugs over the last 25 years. (Journal of Natural Products)
  9. Lessons from 60 years of pharmaceutical innovation (Nature reviews. Drug discovery)
  10. The odyssey of marine pharmaceuticals: a current pipeline perspective. (TIPS - Trends in Pharmacological Sciences)

Their papers